Peptides for Therapy and Diagnosis of Alzheimer’s Disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with devastating effects. The greatest risk factor to develop AD is age. Today, only symptomatic therapies are available. Additionally, AD can be diagnosed with certainty only post mortem, whereas the diagnosis “probable AD” can be...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Bentham Science Publishers
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426787/ |